Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jae-Cheol Lee

Showing results (121-130 of 226) with videos related to

Pageof 23
Sort By:
Cell Death & Disease|July 29, 2021
Exosomal miR-1260b derived from non-small cell lung cancer promotes tumor metastasis through the inhibition of HIPK2Dong Ha Kim, Hyojeong Park, Yun Jung Choi, et al.
Food Science and Biotechnology|June 26, 2020
Improvement of viscous substance production during <i>Cheonggukjang</i> fermentation added with glycineHa Gyoon Na, Min-Ah Kim, Ji Woo Shin, et al.
Tuberculosis and Respiratory Diseases|October 9, 2013
Neuroendocrine differentiation in acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitorYoujin Chang, Seon Ye Kim, Yun Jung Choi, et al.
Oncology Reports|February 13, 2009
Gefitinib circumvents hypoxia-induced drug resistance by the modulation of HIF-1alphaJin Kyung Rho, Yun Jung Choi, Jin Kyung Lee, et al.
Biological & Pharmaceutical Bulletin|June 2, 2009
Rapamycin down-regulates inducible nitric oxide synthase by inducing proteasomal degradationHye Kyoung Jin, Seong Hoon Ahn, Jong Woo Yoon, et al.
BMC Cancer|July 30, 2015
P-glycoprotein confers acquired resistance to 17-DMAG in lung cancers with an ALK rearrangementHee Joung Kim, Kye Young Lee, Young Whan Kim, et al.
Annals of Thoracic Medicine|February 16, 2017
Association between thyroid cancer and epidermal growth factor receptor mutation in female with nonsmall cell lung cancerSeo Yun Kim, Hye-Ryoun Kim, Cheol Hyeon Kim, et al.
Scientific Reports|October 5, 2021
Contribution of p53 in sensitivity to EGFR tyrosine kinase inhibitors in non-small cell lung cancerSangyong Jung, Dong Ha Kim, Yun Jung Choi, et al.
Journal of Cancer Research and Clinical Oncology|September 6, 2022
Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in patients with recurrent non-small cell lung cancer after definitive concurrent chemoradiation or radiotherapyJaewon Hyung, Hyunseok Yoon, Chang-Min Choi, et al.
The Journal of Pharmacy and Pharmacology|April 14, 2007
Suppression of the NF-kappaB signalling pathway by ergolide, sesquiterpene lactone, in HeLa cellsJae Kwang Chun, Dong-Wan Seo, Seong Hoon Ahn, et al.
Pageof 23

Showing results (121-130 of 226) with videos related to

Sort By:
Pageof 23
Cell Death & Disease|July 29, 2021
Exosomal miR-1260b derived from non-small cell lung cancer promotes tumor metastasis through the inhibition of HIPK2Dong Ha Kim, Hyojeong Park, Yun Jung Choi, et al.
Food Science and Biotechnology|June 26, 2020
Improvement of viscous substance production during <i>Cheonggukjang</i> fermentation added with glycineHa Gyoon Na, Min-Ah Kim, Ji Woo Shin, et al.
Tuberculosis and Respiratory Diseases|October 9, 2013
Neuroendocrine differentiation in acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitorYoujin Chang, Seon Ye Kim, Yun Jung Choi, et al.
Oncology Reports|February 13, 2009
Gefitinib circumvents hypoxia-induced drug resistance by the modulation of HIF-1alphaJin Kyung Rho, Yun Jung Choi, Jin Kyung Lee, et al.
Biological & Pharmaceutical Bulletin|June 2, 2009
Rapamycin down-regulates inducible nitric oxide synthase by inducing proteasomal degradationHye Kyoung Jin, Seong Hoon Ahn, Jong Woo Yoon, et al.
BMC Cancer|July 30, 2015
P-glycoprotein confers acquired resistance to 17-DMAG in lung cancers with an ALK rearrangementHee Joung Kim, Kye Young Lee, Young Whan Kim, et al.
Annals of Thoracic Medicine|February 16, 2017
Association between thyroid cancer and epidermal growth factor receptor mutation in female with nonsmall cell lung cancerSeo Yun Kim, Hye-Ryoun Kim, Cheol Hyeon Kim, et al.
Scientific Reports|October 5, 2021
Contribution of p53 in sensitivity to EGFR tyrosine kinase inhibitors in non-small cell lung cancerSangyong Jung, Dong Ha Kim, Yun Jung Choi, et al.
Journal of Cancer Research and Clinical Oncology|September 6, 2022
Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in patients with recurrent non-small cell lung cancer after definitive concurrent chemoradiation or radiotherapyJaewon Hyung, Hyunseok Yoon, Chang-Min Choi, et al.
The Journal of Pharmacy and Pharmacology|April 14, 2007
Suppression of the NF-kappaB signalling pathway by ergolide, sesquiterpene lactone, in HeLa cellsJae Kwang Chun, Dong-Wan Seo, Seong Hoon Ahn, et al.
Pageof 23